Bastide Le Confort Médical SA (EPA:BLC)

EPA:BLC Financials Overview

Financials in millions EUR. Fiscal year is July - June.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue Revenue Growth	476.02	491.18	461.87	508.03	468.3	444.07
Revenue Growth	-3.09%	6.35%	-9.09%	8.48%	5.46%	16.04%
Gross Profit Gross Profit Growth	256.61	188.03	170.6	184.6	174.35	161.09
Operating Income Operating Income Growth	106.86	27.02	6.66	23.16	20.13	23.02
Net Income Net Income Growth	29.45	0.53	-0.9	12.05	13.68	13.45
Earnings Per Share EPS Growth	3.86	0.07	-0.12	1.52	1.86	1.83
EPS Growth	5414.29%	-	-	-18.28%	1.64%	15.82%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Respiratory Support Respiratory Support Growth	129.21	123.89	108.12	92.57	80.83	113.8
Nutrition Infusion Nutrition Infusion Growth	86.41	85.79	81.45	73.94	58.96	100.28
Diabetes Diabetes Growth	30.83	27.26	21.97	17.51	14.33	-
Stomatherapy-Urology-Healing Stomatherapy-Urology-Healing Growth	27.1	26.15	25.33	38	45.63	-
Home Support Home Support Growth	197.21	191.79	190.56	195.52	193.32	230
Others Others Growth	-	-	0.05	0.06	-	-
Unallocated Foreign Subsidiaries Unallocated Foreign Subsidiaries Growth	39.51	36.3	34.39	90.43	75.24	-
Total Total Growth	510.46	491.18	461.87	508.03	468.3	444.07

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Investments Cash & Investments Growth	25.47	25.49	9.6	36.71	22.13	33.74
Total Debt Total Debt Growth	324.13	411.16	435.02	427.39	419.23	357.62
Net Cash (Debt) Net Cash Growth	-298.66	-385.67	-425.41	-390.69	-397.1	-323.88
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-37.63	-48.59	-53.57	-49.22	-53.86	-44.02

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Cash Flow Operating Cash Flow Growth	106.43	101.82	73.91	105.68	56.86	74.36
Capital Expenditures CapEx Growth	-49.05	-60.08	-49.45	-53.63	-53.27	-46.51
Free Cash Flow Free Cash Flow Growth	57.38	41.74	24.46	52.05	3.59	27.85
Free Cash Flow Growth	37.46%	70.68%	-53.01%	1351.37%	-87.12%	269.46%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Gross Margin	53.91%	38.28%	36.94%	36.34%	37.23%	36.28%
Operating Margin	22.45%	5.50%	1.44%	4.56%	4.30%	5.18%
Pretax Margin	2.43%	2.15%	2.84%	4.48%	4.49%	4.54%
Profit Margin	1.62%	0.82%	1.41%	3.31%	3.22%	3.23%
FCF Margin	12.05%	8.50%	5.30%	10.24%	0.77%	6.27%

Dividends

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Dividend Per Share Dividend Per Share Growth	-	-	-	-	0.270
Dividend Per Share Growth	-	-	-	-	0%
Dividend Yield	0.24%	1.21%	0.29%	0.93%	0.61%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 3, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
PE Ratio	19.36	447.14	-	18.82	18.98	25.96
Forward PE	13.64	10.15	6.01	8.91	12.44	18.40
P/FCF Ratio	3.13	5.56	5.49	4.02	71.65	12.48
PS Ratio	0.34	0.47	0.29	0.41	0.55	0.78

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Feb 15, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Semi-annually

Last checked:

Jul 29, 2026

Data Sources Report a data error